ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselNovartis International Pharmaceutical Investment AG
Novartis International Pharmaceutical Investment AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

Novartis International Pharmaceutical Investment AG is a pharmaceutical company that develops, manufactures and commercializes medicines and therapies. It conducts research and development across multiple therapeutic areas including cardiovascular, immunology, neuroscience and oncology, and supports manufacturing and distribution of products.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.9/5

Novartis International Pharmaceutical Investment AG

✓ Offered1
Pharmaceutical site operations
Operation of the pharmaceutical site in Basel with company address plus phone and fax details; the page places the entity in Novartis's pharmaceuticals division.
Trust & reputation

ranQ Trust Score of Novartis International Pharmaceutical Investment AG: 3.9 out of 5.0

Trust Score3.9/ 5.0

High

x

Data basis 100% · As of October 2026

Novartis International Pharmaceutical Investment AG scores 47.6 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.50.024%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.17.610%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.78.08%
Novartis International Pharmaceutical Investment AG scores 87.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.90.07%
Novartis International Pharmaceutical Investment AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Novartis International Pharmaceutical Investment AG scores 60.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.20.04%
Qualifications+0.00

Novartis International Pharmaceutical Investment AG reaches a ranQ Trust Score of 3.9 out of 5.0 — rated «High». The rating draws, among other things, on 1.0 out of 5 stars from 1 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
1
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle11
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

April 12, 2025Media
Amid tariff threats: Novartis’ pledge to invest $23 billion in the USA is revealing
fuw.ch

Knowledge

No knowledge articles yet

Once Novartis International Pharmaceutical Investment AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Novartis International Pharmaceutical Investment AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Novartis International Pharmaceutical Investment AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Novartis International Pharmaceutical Investment AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lichtstr. 35
4056 Basel
Opening hours
Mon
08:00 - 17:00
Tue
08:00 - 17:00
Wed
08:00 - 17:00
Thu
08:00 - 17:00
Fri
08:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-296.204.846
Founded
2017 · 9 years
Last commercial register change
September 25, 2026
Employees
51 to 100
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MD
    Mundipharma Distribution GmbH
    Basel
    MM
    Mundipharma MEA GmbH
    Basel
    RA
    Rhenochem AG
    Basel
    RA
    Rhenopharma AG
    Basel
    TH
    ten23 Health AG
    Basel
    H-
    Hoffmann - La Roche Ltd
    Basel
    CS
    Capsugel Switzerland AG
    Basel
    SA
    Sandoz AG
    Basel